A patient in her late 40s comes in for her annual visit. She mentions, almost in passing, that she’s been more forgetful lately, losing her train of thought mid-sentence, struggling to keep up at work in a way she never used to. The default read is perimenopause and it may well be part of the picture. But here’s what I want primary care providers to know: for a meaningful subset of these patients, what’s surfacing isn’t just hormonal fog. It’s ADHD that’s been present, and quietly compensated for, for decades.
You’re often the first point of contact when this happens. Knowing what to listen for can shorten a patient’s path to an accurate diagnosis by years; sometimes by an entire lifetime of feeling like she was just bad at things everyone else found easy.
Why Perimenopause Uncovers ADHD
Many providers don’t realize how differently ADHD presents in women, and how much that difference has cost in missed diagnoses. Women are more likely to present with the inattentive subtype rather than hyperactivity. That means they are less disruptive in a classroom or a meeting, and easier to overlook. Many girls and women also build compensatory systems early in life: over-preparation, perfectionism, or an almost complete dependence on routine. These systems work well enough to mask real, lifelong symptoms and avoid a childhood diagnosis entirely.
Perimenopause is where those systems start to fail. That’s not a coincidence. Research on ADHD across the female lifespan bears this out, and there’s a physiological reason for it, worth understanding before your next patient describes this exact pattern.
The Estrogen-Dopamine Connection
Let’s talk about why this happens biologically, because it changes how you listen to the patient’s history. Estrogen has a direct, well-documented relationship with dopamine signaling in the brain. Estrogen supports dopamine synthesis and helps regulate its reuptake and breakdown. In a brain that already manages dopamine differently, such as in ADHD, estrogen has effectively been providing quiet, additional support for years. As estrogen becomes erratic and then declines through perimenopause, that support becomes unreliable, and the underlying dopamine regulation problem becomes visible for the first time.
Current research frames this as converging deficits: when estrogen and dopamine are both already low or fluctuating in a patient with an underlying vulnerability, the two shortages reinforce each other, and the impact shows up across mood, memory, sleep, and cognitive function. This is why some women get their first real diagnostic clarity in their 40s or 50s — not because ADHD is new, but because the coping mechanisms that carried them through decades of undiagnosed symptoms finally stop being enough.
Perimenopause Brain Fog vs. ADHD
Evaluating ADHD in perimenopausal women can be a challenge because the symptom lists overlap substantially. Symptoms such as difficulty concentrating, forgetfulness, emotional reactivity, and disrupted sleep are common when estrogen declines. Differentiating between ADHD and perimenopause symptoms in a single visit is genuinely hard, and I don’t think it should be treated as a five-minute judgment call.
A few distinctions are worth building into your history-taking instead:
Timeline. Perimenopausal cognitive symptoms are new to this life stage and tend to track with other perimenopausal signs (irregular cycles, hot flashes, sleep disruption). ADHD-related difficulty is lifelong, even if it was mild, well-managed, or attributed to something else such as busyness, personality, or “just being scattered.” Ask directly: was any version of this present in school, in early adulthood, or in prior jobs, even if it wasn’t a problem then?
Pattern. Perimenopausal brain fog tends to fluctuate with the hormonal cycle and can improve with hormone therapy. ADHD-related executive dysfunction is more consistent and situational. It shows up specifically around tasks that require sustained attention, organization, or working memory, regardless of hormonal timing.
Function before now. Ask how the patient managed demanding tasks in her 20s and 30s. A history of relying heavily on external structure (lists, reminders, a highly organized partner, routines that could not be disrupted) to function normally is a signal worth pursuing, especially if that structure is what’s now breaking down under increased life demands.
Comorbid presentation. Women with undiagnosed ADHD frequently carry prior diagnoses of anxiety or depression, sometimes with a history of medication trials that partially helped or didn’t help as expected. A history of several antidepressant trials with incomplete response, layered with lifelong organizational struggles, is a reasonable prompt to screen for ADHD specifically.
Practical ADHD Screening Approach in Perimenopause
You don’t need to run a full diagnostic workup in a 15-minute visit, and I wouldn’t want you to try. What’s useful is a low-friction way to flag patients who warrant a closer look:
- The ASRS-5 (Adult ADHD Self-Report Scale) is validated for primary care, brief enough for a routine visit, and has shown strong sensitivity and specificity as a first-pass screen.
- Ask about functioning across domains, not just symptoms in isolation. What is their work performance, household management, financial follow-through, and relationship friction telling you?
- Collateral information helps, when it’s available. A partner, adult child, or close friend often notices patterns the patient has long since normalized and stopped seeing in herself.
- A positive screen is a reason to refer, not a diagnosis. The structured interviews used to confirm ADHD, like the DIVA-5, belong with a psychiatrist or psychologist trained in adult ADHD assessment. It’s important to note that a referral is not a signal there is a gap in your role. It’s the next appropriate step.
When to Refer Perimenopause Patients
A referral to psychiatry, or to a specialist trained in adult ADHD assessment, makes sense any time a screen comes back positive alongside a childhood or early-adulthood history that fits, or when prior treatment for anxiety or depression has been partial at best while executive function complaints persist independent of mood. It also makes sense when a patient describes a lifelong pattern of compensatory strategies that are now failing under increased demands, or when you’re simply not sure how much of what you’re seeing is hormonal, psychiatric, or both. That last kind of uncertainty isn’t a failure on your part — it’s exactly the overlap a specialist’s structured evaluation exists to sort out, according to the AAFP’s own adult ADHD toolkit for family physicians.
It’s worth normalizing this referral conversation for the patient herself. Many women reach midlife having spent years being told they were anxious, overwhelmed, or simply bad at managing their lives. Telling her there may be a specific, treatable reason this has always been harder for her than it looked for everyone else tends to land as relief, not as one more diagnosis added to a pile.
What to Remember as a Provider of Perimenopause Patients
Perimenopause doesn’t cause ADHD. It exposes it. For patients who have spent decades building quiet workarounds for a brain that manages attention and reward differently, the hormonal shifts of midlife can be the first time those workarounds visibly stop working. This is not because she’s declining, but because she’s finally out of runway to keep compensating alone. Recognizing that pattern in a routine visit, and knowing when to screen and refer, is often the difference between another year of “just anxious, just tired, just getting older” and a diagnosis that actually explains her life.
This article is intended for clinical education. It is not a substitute for individualized diagnostic evaluation. Further reading: ADDA on ADHD and perimenopause, the ASRS-5 primary care validation study, and the 2025 review on hormonal fluctuations in female ADHD.